Article

ASCRS launches ectasia registry

The American Society of Cataract and Refractive Surgery (ASCRS) has launched the ASCRS International Ectasia Registry as part of a two-phase project to define ectasia more precisely, determine its frequency, and identify risk factors.

Fairfax, VA-The American Society of Cataract and Refractive Surgery (ASCRS) has launched the ASCRS International Ectasia Registry as part of a two-phase project to define ectasia more precisely, determine its frequency, and identify risk factors.

The project is directed by R. Doyle Stulting, MD, PhD, professor of ophthalmology, Emory University, Atlanta, and chairman of the ASCRS Refractive Clinical Committee.

During the first phase of the project, data on post-LASIK ectasia will be gathered and physicians and patients will be identified for future participation in the second phase's prospective observational studies. These studies will aim to determine the incidence of ectasia and more precisely quantify the impact of preoperative factors.

Physicians and researchers can register and submit data immediately at http://www.ectasiaregistry.com/. Those who have medical questions about the registry should contact Dr. Stulting at ophtrds@emory.edu
. Technical questions about the registry should be directed to Barbara S. Fant, PharmD, of Clinical Research Consultants Inc., at bsfant@crc-regulatory.com
.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.